CHConor M. Henry

Conor M. Henry

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Conor M. Henry has a total of 52 co-authors. Here are the top co-authors by number of shared publications:

  • Seamus J. Martin

    Molecular Cell Biology Laboratory, Dept. of Genetics, The Smurfit Institute, Trinity College, Dublin 2, Ireland

    14 shared publications
  • Danielle M. Clancy

    Molecular Cell Biology Laboratory, Department of Genetics, The Smurfit Institute, Trinity College, Dublin, Ireland

    7 shared publications
  • Graeme P. Sullivan

    Molecular Cell Biology Laboratory, Department of Genetics, The Smurfit Institute, Trinity College, Dublin, Ireland

    7 shared publications
  • Sean P. Cullen

    Department of Cancer Immunology, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, USA

    4 shared publications
  • Caetano Reis e Sousa

    Immunobiology Laboratory, The Francis Crick Institute, London, UK

    3 shared publications
  • Ekaterina Belotcerkovskaya

    Cellular Biotechnology Laboratory Saint-Petersburg State Institute of Technology Russia

    3 shared publications

Latest Publications

  • Open Access

    DNGR-1-mediated cross-presentation of dead cell-associated antigens

    by Conor M. Henry, Carlos A. Castellanos, Caetano Reis e Sousa


  • Open Access

    Maintenance and loss of endocytic organelle integrity: mechanisms and implications for antigen cross-presentation

    by Eleanor Childs, Conor M. Henry, Johnathan Canton, Caetano Reis e Sousa

    The membranes of endosomes, phagosomes and macropinosomes can become damaged by the physical properties of internalized cargo, by active pathogenic invasion or by cellular processes, including endocytic maturation. Loss of membrane integrity is often deleterious and is, therefore, prevented by mitigation and repair mechanisms. However, it can occasionally be beneficial and actively induced by cells. Here, we summarize the mechanisms by which cells, in particular phagocytes, try to prevent membrane damage and how, when this fails, they repair or destroy damaged endocytic organelles. We also detail how one type of phagocyte, the dendritic cell, can deliberately trigger localized damage to endocytic organelles to allow for major histocompatibility complex class I presentation of exogenous antigens and initiation of CD8 + T-cell responses to viruses and tumours. Our review highlights mechanisms for the regulation of endocytic organelle membrane integrity at the intersection of cell biology and immunology that could be co-opted for improving vaccination and intracellular drug delivery.


  • TRAIL Receptors Serve as Stress-Associated Molecular Patterns to Promote ER-Stress-Induced Inflammation

    by Graeme P. Sullivan, Hazel O’COnnor, Conor M. Henry, Pavel Davidovich, Danielle M. Clancy, Matthew L. Albert, Sean P. Cullen, Seamus J. Martin


  • Open Access

    α-actinin accounts for the bioactivity of actin preparations in inducing STAT target genes in Drosophila melanogaster

    by Oliver Gordon, Conor M Henry, Naren Srinivasan, Susan Ahrens, Anna Franz, Safia Deddouche, Probir Chakravarty, David Phillips, Roger George, Svend Kjaer, et al.

    Damage-associated molecular patterns (DAMPs) are molecules exposed or released by dead cells that trigger or modulate immunity and tissue repair. In vertebrates, the cytoskeletal component F-actin is a DAMP specifically recognised by DNGR-1, an innate immune receptor. Previously we suggested that actin is also a DAMP in Drosophila melanogaster by inducing STAT-dependent genes (Srinivasan et al., 2016). Here, we revise that conclusion and report that α-actinin is far more potent than actin at inducing the same STAT response and can be found in trace amounts in actin preparations. Recombinant expression of actin or α-actinin in bacteria demonstrated that only α-actinin could drive the expression of STAT target genes in Drosophila. The response to injected α-actinin required the same signalling cascade that we had identified in our previous work using actin preparations. Taken together, these data indicate that α-actinin rather than actin drives STAT activation when injected into Drosophila.


  • Open Access

    Identification of small‐molecule elastase inhibitors as antagonists of IL‐36 cytokine activation

    by Graeme P. Sullivan, Pavel B. Davidovich, Sylvia Sura‐Trueba, Ekaterina Belotcerkovskaya, Conor M. Henry, Danielle M. Clancy, Anna Zinoveva, Tazhir Mametnabiev, Alexander V. Garabadzhiu, Seamus J. Martin

    IL-1 family cytokines act as apical initiators of inflammation in many settings and can promote the production of a battery of inflammatory cytokines, chemokines and other inflammatory mediators in diverse cell types. IL-36α, IL-36β and IL-36γ, which belong to the extended IL-1 family, have been implicated as key initiators of skin inflammation in psoriasis. IL-36γ is highly upregulated in lesional skin from psoriatic individuals and heritable mutations in the natural IL-36 receptor antagonist result in a severe form of psoriasis. IL-36 family cytokines are initially expressed as inactive precursors that require proteolytic processing for activation. The neutrophil granule-derived protease, elastase, proteolytically processes and activates IL-36α and IL-36γ, increasing their biological activity ~500-fold, and also robustly activates IL-1α and IL-33 through limited proteolytic processing. Consequently, inhibitors of elastase activity may have potential as anti-inflammatory agents through antagonizing the activation of multiple IL-1 family cytokines. Using in silico screening approaches, we have identified small molecule inhibitors of elastase that can antagonize activation of IL-36γ by the latter protease. The compounds reported herein may have utility as lead compounds for the development of inhibitors of elastase-mediated activation of IL-36 and other IL-1 family cytokines in inflammatory conditions, such as psoriasis.


  • Open Access

    Suppressing IL-36-driven inflammation using peptide pseudosubstrates for neutrophil proteases

    by Graeme P. Sullivan, Conor M. Henry, Danielle M. Clancy, Tazhir Mametnabiev, Ekaterina Belotcerkovskaya, Pavel Davidovich, Sylvia Sura-Trueba, Alexander V. Garabadzhiu, Seamus J. Martin

    Sterile inflammation is initiated by molecules released from necrotic cells, called damage-associated molecular patterns (DAMPs). Members of the extended IL-1 cytokine family are important DAMPs, are typically only released through necrosis, and require limited proteolytic processing for activation. The IL-1 family cytokines, IL-36α, IL-36β, and IL-36γ, are expressed as inactive precursors and have been implicated as key initiators of psoriatic-type skin inflammation. We have recently found that IL-36 family cytokines are proteolytically processed and activated by the neutrophil granule-derived proteases, elastase, and cathepsin G. Inhibitors of IL-36 processing may therefore have utility as anti-inflammatory agents through suppressing activation of the latter cytokines. We have identified peptide-based pseudosubstrates for cathepsin G and elastase, based on optimal substrate cleavage motifs, which can antagonize activation of all three IL-36 family cytokines by the latter proteases. Human psoriatic skin plaques displayed elevated IL-36β processing activity that could be antagonized by peptide pseudosubstrates specific for cathepsin G. Thus, antagonists of neutrophil-derived proteases may have therapeutic potential for blocking activation of IL-36 family cytokines in inflammatory conditions such as psoriasis.


  • Open Access

    Extracellular Neutrophil Proteases Are Efficient Regulators of IL-1, IL-33, and IL-36 Cytokine Activity but Poor Effectors of Microbial Killing

    by Danielle M. Clancy, Graeme P. Sullivan, Hannah B.T. Moran, Conor M. Henry, Emer P. Reeves, Noel G. McElvaney, Ed C. Lavelle, Seamus J. Martin


  • Neutrophil extracellular traps can serve as platforms for processing and activation of IL‐1 family cytokines

    by Danielle M. Clancy, Conor M. Henry, Graeme P. Sullivan, Seamus J. Martin

    Activated neutrophils can undergo a mode of regulated cell death, called NETosis, that results in the extrusion of chromatin into the extracellular space, thereby acting as extracellular traps for microorganisms. Neutrophil‐derived extracellular traps (NETs) are comprised of DNA decorated with histones, antimicrobial proteins and neutrophil granule proteases, such as elastase and cathepsin G (Cat G). NET‐associated factors are thought to enhance the antimicrobial properties of these structures and localisation of antimicrobial molecules on NETs may serve to increase their local concentration. Because neutrophil‐derived proteases have been implicated in the processing and activation of several members of the extended interleukin (IL)‐1 family, we wondered whether neutrophil NETs could also serve as platforms for the activation of proinflammatory cytokines. Here, we show that neutrophil NETs potently processed and activated IL‐1α as well as IL‐36 subfamily cytokines through NET‐associated Cat G and elastase. Thus, in addition to their role as antimicrobial traps, NETs can also act as local sites of cytokine processing and activation.


  • Open Access

    Production of biologically active IL‐36 family cytokines through insertion of N‐terminal caspase cleavage motifs

    by Danielle M. Clancy, Conor M. Henry, Pavel B. Davidovich, Graeme P. Sullivan, Ekaterina Belotcerkovskaya, Seamus J. Martin

    Recent evidence has strongly implicated IL‐36 cytokines as key initiators of inflammation in the skin barrier. IL‐36 cytokines belong to the extended IL‐1 family and, similar to most members of this family, are expressed as inactive precursors that require proteolytic processing for activation. Because the proteases responsible for activation of members of the IL‐36 subfamily have not been reported, we have developed a method for the production of biologically active IL‐36 through introduction of a caspase cleavage motif, DEVD, within the N‐termini of these cytokines. Here, we show that DEVD‐modified IL‐36α, IL‐36β and IL‐36γ cytokines were highly soluble and were readily processed and activated by caspase‐3. Caspase‐3‐processed IL‐36 family cytokines exhibited robust biological activity on a range of responsive cell types, including primary keratinocytes. We also generated specific polyclonal antibodies against all three IL‐36 family members through immunization with purified recombinant IL‐36 cytokines. The modified forms of IL‐36 described herein will be useful for production of large quantities of biologically active IL‐36 for structure and function studies on these important proinflammatory cytokines.